Aliso Viejo, CA – According to filings with the U.S. Securities and Exchange Commission, Okami Medical is raising $7,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Robert Rosenbluth played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Okami Medical
Okami Medical was formed to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive medical devices for the occlusion of peripheral vessels. Okami believes that vessel occlusion should be rapid and reliable regardless of tortuosity and flow conditions. The LOBO Vascular Occlusion System was developed for this reason.

To learn more about Okami Medical, visit http://okamimedical.com/

Contact:
Robert Rosenbluth, Chief Executive Officer
949-446-9710
https://www.linkedin.com/in/bob-rosenbluth-50558115/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved